• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

295.8900 USD 0.8100 0.27%

As of 15:44:59 ET on 10/31/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 301.2200 High - Low: 302.9790 - 295.3000 Primary Exchange: NASDAQ GM
Volume: 1,565,469 52-Week Range: 197.4400 - 302.9790 Beta vs XNBI: 0.9994

ETF Chart for IBB

No chart data available.
  • IBB:US 295.9000
  • 1D
  • 1M
  • 1Y
296.7000
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-10-30) 296.6500
Assets (M) (on 2014-10-30) 6,200.0500
Shares out (M) 20.90
Market Cap (M) 6,177.20
% Premium 0.02
Average 52-Week % Premium 0.0025
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +8.43% 1-Year +43.41%
3-Month +15.36% 3-Year +43.78%
Year To Date +30.90% 5-Year +32.56%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 10/30/2014
Name Position Value % of Total
Amgen Inc 3,363,094 543,408,729 8.765%
Celgene Corp 4,933,154 527,551,489 8.509%
Gilead Sciences Inc 4,357,208 497,680,298 8.027%
Regeneron Pharmaceuticals Inc 1,162,677 456,699,526 7.366%
Biogen Idec Inc 1,366,456 438,632,376 7.075%
Vertex Pharmaceuticals Inc 2,504,814 277,658,632 4.479%
Alexion Pharmaceuticals Inc 1,384,461 267,104,061 4.308%
Illumina Inc 1,306,733 252,748,297 4.077%
Mylan Inc/PA 4,797,445 251,242,195 4.052%
BioMarin Pharmaceutical Inc 1,886,901 155,405,166 2.507%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil